Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2010

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSomayeh Hallaj‐NezhadiTabriz University of Medical SciencesFLFarzaneh LotfipourUniversity of OttawaCDCrispin R DassVictoria University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hallaj‐Nezhadi et al. (2010) studied this question.

synapsesocial.com/papers/6a8b8dca1692ae2bc0f462dehttps://doi.org/10.1691/ph.2010.0168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Naked siLNA-Mediated Gene Silencing of Lung Bronchoepithelium EGFP Expression After Intravenous Administration2009 · 53 citations
  2. 2Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA2008 · 195 citations
  3. 3IONP‐PLL: a novel non‐viral vector for efficient gene delivery2003 · 92 citations